Modafinil add-on in the treatment of bipolar depression

American Journal of Psychiatry

Volumn 164, Issue 8, 2007, Pages 1143-1145

  Belmaker, R H ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; METHYLPHENIDATE; MODAFINIL; MOOD STABILIZER; PLACEBO; SERTRALINE;

ADD ON THERAPY; ATTENTION DEFICIT DISORDER; BIPOLAR DEPRESSION; DRUG ABUSE; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HEALTH CARE DELIVERY; HEALTH PROGRAM; HUMAN; NARCOLEPSY; NONHUMAN; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; BENZHYDRYL COMPOUNDS; BIPOLAR DISORDER; CENTRAL NERVOUS SYSTEM STIMULANTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; HUMANS; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 34548085721     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2007.07050749     Document Type: Editorial

References (9)

1. Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P, Rapport D, Martinez JM, Allen MH, Miklowitz DJ, Otto MW, Dennehy EB, Thase ME: Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007; 356:1711-1722
2. Fava M, Thase ME, DeBattista C: A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. J Clin Psychiatry 2005; 66:85-93
3. Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM: Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry 2004; 161:1537-1547
4. Post RM, Altshuler LL, Leverich GS, Frye MA, Nolen WA, Kupka RW, Suppes T, McElroy S, Keck PE, Denicoff KD, Grunze H, Walden J, Kitchen CM, Mintz J: Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry 2006; 189:124-131
5. Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patelis-Siotis I: Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry 2000; 157:124-126
6. Parmentier R, Anaclet C, Guhennec C, Brousseau E, Bricout D, Giboulot T, Bozyczko-Coyne D, Spiegel K, Ohtsu H, Williams M, Lin JS: The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders. Biochem Pharmacol 2007; 73:1157-1171
7. Scammell TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS, Saper CB: Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000; 20:8620-8628
8. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK: A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63:856-864
9. Nabkasorn C, Miyai N, Sootmongkol A, Junprasert S, Yamamoto H, Arita M, Miyashita K: Effects of physical exercise on depression, neuroendocrine stress hormones and physiological fitness in adolescent females with depressive symptoms. Eur J Public Health 2006; 16:179-184